...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zhlcf

Even more puzzling is it traded at 4 cents a week ago.

Share
New Message
Please login to post a reply